Wiesbaden, Germany

Hayat Bähr-Mahmud

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hayat Bähr-Mahmud: Innovator in Cancer Treatment

Introduction

Hayat Bähr-Mahmud is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of binding agents.

Latest Patents

Hayat Bähr-Mahmud holds 1 patent for his invention titled "Agents for treatment of claudin expressing cancer diseases." This patent provides binding agents that contain a binding domain specific for CD3, allowing interaction with T cells, and a binding domain specific for a tumor-associated claudin molecule. The methods described in this patent are aimed at treating cancer effectively.

Career Highlights

Throughout his career, Hayat has worked with prominent companies in the biotechnology sector, including BioNTech AG and Ganymed Pharmaceuticals GmbH. His work in these organizations has contributed to advancements in cancer therapies and immunotherapy.

Collaborations

Hayat has collaborated with esteemed colleagues, including Ugur Sahin and Özlem Türeci, who are also recognized for their contributions to cancer research and treatment.

Conclusion

Hayat Bähr-Mahmud's innovative work in developing targeted cancer treatments showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patent reflects the potential for significant impact in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…